New observations on the utility of CA19-9 as a biomarker in Lewis negative patients with pancreatic cancerGuopei Luo, Xianjun Yu, Meng Guo et al.|Pancreatology|2018Cited by 79
The combination of systemic inflammation-based marker NLR and circulating regulatory T cells predicts the prognosis of resectable pancreatic cancer patientsCheng He, Chen Liu, Guopei Luo et al.|Pancreatology|2016Cited by 65